| Tumor immunogenicity dictates reliance on TCF1 in CD8+ T cells for response to immunotherapy G Escobar, K Tooley, JP Oliveras, L Huang, H Cheng, ML Bookstaver, ... Cancer cell 41 (9), 1662-1679. e7, 2023 | 24 | 2023 |
| Diet Quality Scores Are Positively Associated with Whole Blood–Derived Mitochondrial DNA Copy Number in the Framingham Heart Study J Ma, X Liu, Y Zhang, H Cheng, W Gao, CQ Lai, S Gabriel, N Gupta, ... The Journal of Nutrition 152 (3), 690-697, 2022 | 9 | 2022 |
| Pan-cancer mapping of single CD8+ T cell profiles reveals a TCF1: CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunity K Tooley, L Jerby, G Escobar, SH Krovi, D Mangani, G Dandekar, ... Cell Reports Medicine 5 (7), 2024 | 4 | 2024 |
| 964 Dynamic immune landscapes during melanoma progression reveal a role for endogenous opioids in driving T cell dysfunction D Mangani, L Huang, M Singer, R Li, R Barilla, G Escobar, K Tooley, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 1 | 2022 |
| Transcription factor TCF1 binds to RORγt and orchestrates a regulatory network that determines homeostatic Th17 cell state D Mangani, A Subramanian, L Huang, H Cheng, SH Krovi, Y Wu, D Yang, ... Immunity 57 (11), 2565-2582. e6, 2024 | | 2024 |
| Tumor context dictates reliance on TCF1 for response to immunotherapy G Escobar, K Tooley, JP Oliveras, L Huang, H Cheng, C Xue, D Mangani, ... Cancer Research 83 (7_Supplement), 4157-4157, 2023 | | 2023 |
| Abstract B35: Tumor context dictates reliance on TCF1 for response to immunotherapy G Escobar, K Tooley, JP Oliveras, C Hanning, X Chang, D Mangani, ... Cancer Immunology Research 10 (12_Supplement), B35-B35, 2022 | | 2022 |
| 514 Tumor context dictates reliance on TCF1 for response to immunotherapy G Escobar, K Tooley, JP Oliveras, C Hanning, X Chang, D Mangani, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
